When a woman starts taking testosterone, the first changes she’ll typically notice are shifts in energy, mood, and sexual desire, often within the first few weeks. Over the following months, physical changes to body composition, skin, and hair gradually follow. The specific timeline and intensity depend on the dose, delivery method, and individual response, but the general pattern is well established.
Most women who take testosterone are doing so for one of two reasons: treatment of low sexual desire after menopause, or as part of gender-affirming hormone therapy. The changes are similar in both cases, though doses differ significantly. Normal testosterone levels in women range from about 15 to 70 ng/dL, and therapeutic approaches for postmenopausal women aim to stay within or slightly above that range, while gender-affirming protocols typically target much higher levels.
Sexual Desire and Arousal
Increased sexual desire is one of the earliest and most consistent effects. Changes in sexual interest typically appear after about three weeks and plateau around six weeks. For postmenopausal women with low desire, testosterone is currently the only evidence-based hormonal treatment for that specific condition. The effect isn’t subtle for many women: it can feel like a switch turning back on after years of diminished interest.
Genital sensitivity also changes. Increased blood flow and nerve sensitivity in the clitoris can heighten arousal, though at higher doses or with prolonged use, clitoral tissue may enlarge noticeably. This is a direct androgenic effect on genital tissue and is more pronounced at the doses used in gender-affirming care.
Mood, Energy, and Mental Clarity
Many women report feeling more energetic and mentally sharp within the first month. In a pilot study of peri- and postmenopausal women using transdermal testosterone for four months, 47% reported improved mood and 39% reported improved cognition. Specific symptoms that improved included fatigue, difficulty concentrating, and memory problems.
Depressive symptoms tend to lift more gradually. Detectable improvements in depressive mood generally appear after three to six weeks, with maximum benefit taking anywhere from four to seven months. Some women describe the shift as feeling more decisive, more motivated, or simply less “flat.” Others notice reduced anxiety, though this varies considerably from person to person.
Body Composition and Strength
Testosterone promotes lean muscle growth and can reduce fat mass. These changes in body composition typically begin around 12 to 16 weeks and stabilize between 6 and 12 months, though marginal gains in muscle can continue over years. Women often notice that strength training produces faster results than it did before, and that their body feels firmer even before the scale changes much.
Bone density also improves, with measurable increases detectable after about six months and continuing for at least three years. For postmenopausal women already losing bone, this can be a meaningful protective effect. Research on a related androgen (DHEA) found increased bone mineral density in the lumbar spine, total hip, and the bony prominence near the hip joint in women specifically.
Skin and Acne
Oilier skin is one of the most common early changes. Testosterone stimulates sebaceous glands to produce more oil, which can lead to acne on the face, back, or chest. This is the same mechanism that drives teenage acne during puberty, and it tends to be most noticeable in the first several months as the body adjusts to new hormone levels.
Some women find that their skin texture changes overall, becoming slightly thicker or rougher. For those prone to acne, managing it with topical treatments early on can help prevent scarring while hormone levels stabilize.
Hair Growth and Hair Loss
Facial hair growth is extremely common. In one large study of women receiving testosterone implant therapy, 92% reported some increase in facial hair. The majority (about 86%) rated it as minimal or moderate, while roughly 6% described it as severe. This usually means fine hairs on the upper lip and chin that may darken over time, particularly at higher doses.
Body hair on the arms, legs, and abdomen may also thicken or grow in new areas. This is a gradual process that continues evolving over months to years.
Scalp hair tells a more complicated story than most people expect. Among women who had thinning hair before starting testosterone, 63% actually reported hair regrowth during treatment. None of the women in that study reported new hair loss as a side effect, even though their testosterone levels averaged four times higher than the upper limit of natural production. The researchers proposed that testosterone has a general anabolic (growth-promoting) effect on hair that can counteract thinning. However, women with higher body mass and likely insulin resistance were less likely to see improvement, possibly because insulin resistance increases the conversion of testosterone to a more potent form (DHT) that drives the pattern-balding process familiar in men.
Voice Changes
At low, physiologic doses used for postmenopausal treatment, significant voice changes are uncommon. At the higher doses used in gender-affirming care, vocal cord thickening leads to a gradual deepening of the voice. This typically begins within the first few months and continues evolving for a year or more. Voice deepening is one of the changes considered largely irreversible, meaning it persists even if testosterone is later discontinued.
Metabolic and Cardiovascular Effects
Testosterone influences cholesterol, insulin sensitivity, and inflammation. Changes in blood lipids appear after about four weeks and reach their full effect between 6 and 12 months. Research on postmenopausal women suggests that low-dose testosterone, particularly when combined with estrogen, may have favorable effects on body composition, functional capacity, insulin sensitivity, and inflammatory markers.
The picture isn’t entirely straightforward, though. Some studies have found mild decreases in HDL (“good”) cholesterol with testosterone use, with no change in LDL. When testosterone and estrogen are used together, the overall effect on total cholesterol tends to be more favorable. Insulin sensitivity may start improving within days, but measurable changes in blood sugar control take three to twelve months to appear.
Red blood cell production also increases, becoming evident around three months and peaking at 9 to 12 months. This is why periodic blood work to check red blood cell counts is standard during testosterone therapy, since excessively high levels can thicken the blood.
How Testosterone Is Taken
Women receive testosterone through several routes: topical creams or gels applied to the skin, subcutaneous pellets inserted under the skin every few months, intramuscular injections, or oral preparations. There is no FDA-approved testosterone product specifically designed for women in the United States, so most prescriptions involve compounded formulations or carefully dosed fractions of products designed for men.
Subcutaneous pellets have been used worldwide for decades and tend to provide the most stable blood levels without the daily peaks and troughs that come with creams or injections. Transdermal creams offer easy dose adjustments but require consistent daily application. The best approach is individualized dosing that targets symptom relief while keeping levels low enough to minimize unwanted androgenic effects like acne and excess hair growth.
What’s Reversible and What Isn’t
Most changes from low-dose testosterone are reversible if treatment stops. Oilier skin, acne, increased libido, and mood effects will gradually fade. Muscle mass gained will decrease without continued use, similar to what happens when anyone stops strength training.
A few changes are partially or fully permanent, especially at higher doses sustained over longer periods. Voice deepening, clitoral growth, and some facial hair changes tend to persist. This distinction matters most for women considering gender-affirming doses, where the goal is often permanent masculinization. For women using physiologic replacement doses for symptoms like low desire or fatigue, the risk of irreversible virilization is low when levels are monitored appropriately.